In the sensitivity analysis restricted to the subgroup of patients that did not receive CMV antiviral prophylaxis ( n = 125), the development during the first 90 days of CMV infection at any level (adjusted HR: 2.54; 95% CI: 1.09–5.90; p -value = 0.030) or high-level viremia (adjusted HR: 2.37; 95% CI: 1.14–4.95; p -value = 0.021) was associated with subsequent non-CMV infection, with borderline significance.
← all excerpts
Cytomegalovirus Exposure and the Risk of Overall Infection After Kidney Transplantation: A Cohort Study on the Indirect Effects Attributable to Viral Replication.
1
—
—